Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiaPep277 in LADA Subjects
NCT00058981Phase 2Terminated
- Sponsor
- DeveloGen AG
- Start
- Oct 2002
- Primary completion
- Mar 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of diapep277 in latent autoimmune diabetes in adults (LADA), sponsored by DeveloGen AG. Started Oct 2002; status: terminated.
02
Drugs
diapep277
03
Conditions
latent autoimmune diabetes in adults (LADA)
Beyond the preview
Go deeper on NCT00058981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058981.